当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

New Histopathological Diagnostic Terms and their Codes of the Central Nervous System (CNS) in the International Classification of Diseases for Oncology (ICD-O 3.1) and about the Turkish Version of ICD-O

M. Serefittin Canda

International Classification of Diseases for Oncology (ICD-O), which has been used in the world since 1976 for 40 years and has been translated into many languages, emphasizing the importance of health and cancer is presented. In addition, the histopathological classification working group of central nervous system (CNS) tumors has proposed new terms and their new ICD-O codes, taking into account their genetic characteristics. Our goal is to emphasize the current importance of ICD-O. Since 2015, ICD-O has been put into practice by the Ministry of Health in Turkey. Writing of ICD-O codes is required for pathology reports. In the last 25 years, I have translated the ICD-O three times into Turkish, 1992, 2002 and 2015, serving as pathology, oncology, cancer registrars and the Ministry of Health.